Changes in concanavalin A-reactive proteins in neurological disorders

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 4, 1999, Pages 158-165

  Saso, Luciano ^a   Valentini, Giovanni ^a   Leone, Maria Grazia ^a   Grippa, Eleonora ^a   Guglielmi, Renzo ^b   Paris, Luciana ^b   Cantore, Gianpaolo ^b   Silvestrini, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

1 antitrypsin; 2 macroglobulin; 2 microglobulin; Glycosylation; Multiple sclerosis; Prostaglandin D synthase

Indexed keywords

CONCANAVALIN A;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROPATHY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION;

ALPHA 1-ANTITRYPSIN; ALPHA-MACROGLOBULINS; BLOOD PROTEINS; CEREBROSPINAL FLUID PROTEINS; CONCANAVALIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MOLECULAR PROBES; MULTIPLE SCLEROSIS;

EID: 0033065679     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:4<158::AID-JCLA4>3.0.CO;2-0     Document Type: Article

References (47)

1. Silvestrini B, Guglielmotti A, Saso L, Cheng CY. Changes in concanavalin A-reactive proteins in inflammatory disorders. Clin Chem 1989;35:2207-11.
2. 1-antitrypsin for diagnostic screening of inflammatory disorders. Clin Chem 1990;36:277-282.
3. 1-antitrypsin in diagnostic screening of inflammatory disorders. Int J Immunoth 1991;7:197-204.
4. Saso L. Silvestrini B, Zwain I, et al. Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit. J Rheumatol 1992;19:1859-1867.
5. 1-antitrypsin in patients with autoimmune diseases. Inflammation 1993;17:383-400.
6. 2-macroglobulin, a non-acute-phase protein, in patients with autoimmune diseases. Inflammation 1993;17:465-479.
7. Guglielmotti A, Silvestrini B, Saso L, Zwain I, Chen CY. Chronic inflammatory response in the rat can be blocked by bindarit. Biochem Mol Biol Int 1993;29:747-756.
8. Panzironi C, Silvestrini B, Mo MY, Lahita R, Mruk D, Cheng CY. An increase in the carbohydrate moiety of alpha 2-macroglobulin is associated with systemic lupus erythematosus (SLE). Biochem Mol Biol Int 1997;43:1305-1322.
9. Cioli V, Ciarniello MG, Guglielmotti A, et al. A new protein anti-denaturant agent, bindarit, reduces secondary phase inflammation in Freund's adjuvant injected rats. J Rheumatol 1992;19:1735-42.
10. Pawlowski T, Aeschlimann A, Kahn MF, Vaith P, Mackiewicz SH, Mueller W. Microheterogeneity of acute phase proteins in the differentiation of polymyalgia rheumatica from polymyositis. J Rheumatol 1990;17:1187-1192.
11. 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus. Arth Rheumat 1987;30:513-518.
12. 1-acid glycoprotein as indicators of rheumatoid arthritis activity. Clin Chim Acta 1987; 163:185-190.
13. Stibler H, Allgulander C, Borg S, Kjellin KG. Abnormal micro-heterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 1978;204:49-56.
14. De Jong G, Feelders R, Van Noort WL, Van Eijk HG. Transferrin microheterogeneity as a probe in normal and disease states. Glycoconj J 1995;12:219-226.
15. Hoffmann A, Nimtz M, Getzlaff R, Conradt HS. "Brain-type" N-glycosylation of asialo-transferrin from human cerebrospinal fluid. FEBS Lett 1995;359:164-168.
16. 2-macroglobulin in multiple sclerosis and other neurological diseases. A study performed by direct immunofixation after isoelectric focusing. Acta Neurol Belg 1985;85:222-228.
17. Hoffmann A, Conradt HS, Gross G, Nimtz M, Lottspeich F, Wurster U. Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem 1993;61:451-456.
18. Watanabe K, Urade Y, Mader M, Murphy C. Identification of β-trace as prostaglandin D synthase. Biochem Biophys Res Commun 1994; 203:1110-1116.
19. Hoffmann A, Nimtz M, Wurster U, Conradt HS. Carbohydrate structures of β-trace protein from human cerebrospinal fluid: evidence for "brain-type" N-glycosylation. J Neurochem 1994;63:2185-2196.
20. Pohl S, Hoffmann A, Rudiger A, Nimtz M, Jaeken J, Conradt HS. Hypoglycosylation of a brain glycoprotein (β-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl-transferase II deficiency. Glycobiology 1997;7:1077-1084.
21. Hiraoka A, Arato T, Tominaga I, Eguchi N, Oda H, Urade Y. Sodium dodecyl sulfate-capillary gel electrophoretic analysis of molecular mass microheterogeneity of β-trace protein in cerebrospinal fluid from patients with central nervous system diseases. J Chromatogr A 1998; 802:143-148.
22. Schieven GL, Blank A, Dekker CA. Ribonucleases of human cerebrospinal fluid: detection of altered glycosylation relative to their serum counterparts. Biochemistry 1982;21:5148-5155.
23. Bernard CC, Kerlero de Rosbo N. Definite multiple sclerosis: an autoimmune disease of multifactorial etiology. Curr Opin Immunol 1992;4760-765.
24. 2-macroglobulin isolated from definite multiple sclerosis serum. Clin Chim Acta 1980;107:141-144.
25. 2-macroglobulin in definite multiple sclerosis. Eur Neurol 1981;20:33-39.
26. 2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting definite multiple sclerosis. Clin Chim Acta 1992;211:27-36.
27. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-390.
28. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in definite multiple sclerosis. Scand J Clin Lab Invest 1977;37:397-401.
29. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
30. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 1992;24:145-149.
31. Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radiolabeled protein A. Anal Biochem 1981;112:195-203.
32. Hawkes R. Identification of concanavalin A-binding proteins after sodium dodecyl sulfate-polyacrylamide gels and protein blotting. Anal Biochem 1982;123:143-146.
33. Leone MG, Saso L, Del Vecchio A, Mo MY, Silvestrini B, Cheng CY. Micropurification of two human cerebrospinal fluid proteins by high performance electrophoresis chromatography. J Neurochem 1993; 61:533-540.
34. Tourtellotte WW. Cerebrospinal fluid and its reactions in diseases. In: Minckler J, editor. Pathology of the nervous system. New York: McGraw-Hill; 1968.
35. Lonberg-Holm K, Reed DL, Roberts RC, Hebert RR, Hillman MC, Kutney RM. Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes. J Biol Chem 1987;262:438-445.
36. 2-Macroglobulin and related thiol ester plasma proteins. In: Putnam FW, editor. The plasma proteins, vol. V. New York: Academic Press; 1987. p 191-291.
37. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med 1961;107:170.
38. Thompson EG, editor. The CSF proteins: a biochemical approach. Amsterdam: Elsevier; 1988.
39. Link H, Olson JE. β-trace protein concentration in CSF in neurological disorders. Acta Neurol Scand 1972;48:57-68.
40. Melegos DN, Freedman MS, Diamandis EP. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins Med 1997;54:463-474.
41. 2-microglobulin in definite multiple sclerosis and AIDS dementia complex. Neurol Res 1992;14:282-283.
42. 2 Microglobulin in cerebrospinal fluid in neurology. Presse Med 1995;24: 1071-1074.
43. 2-microglobulin is related to neurologic impairment in definite multiple sclerosis. Acta Neurol Scand 1988;78:72-75.
44. 2-Microglobulin levels in cerebrospinal fluid - the levels in various neurological diseases and their comparison with those in serum. Rinsho Shinkeigaku 1978;18:351-357.
45. 2-microglobulin in definite multiple sclerosis and aseptic meningo-encephalitis. Acta Neurol Scand 1989;80:598-602.
46. 2-Microglobulin levels in the cerebrospinal fluid: their value as a disease marker. A review of the recent literature. Eur Neurol 1991;31:181-185.
47. Watson MA, Scott MG. Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem 1995;41:343-360.